Institute for Viral Hepatitis, Key Laboratory of Molecular Biology for Infectious Diseases, Chinese Ministry of Education, Department of Infectious Diseases, Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
Pediatric Research Institute, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, 400014, China; China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, 400014, China.
Carbohydr Polym. 2018 Oct 1;197:540-547. doi: 10.1016/j.carbpol.2018.05.052. Epub 2018 May 21.
The present study examined the role of a polysaccharide (LSP, 25 and 100 μg/ml) from the fruiting bodies of Lepista sordid on the immunosuppressive enzyme indoleamine 2, 3-dioxygenase (IDO) in HepG2 cells, and the possible mechanism of action. IDO expression and kynurenine production from LSP-treated HepG2 cells following IFN-γ stimulation were dramatically inhibited by LSP treatment. In line with this, the medium of HepG2 cells pretreated with LSP improved the survival rate of primary CD4+ and CD8+ T cells as compared with IFN-γ-treated control cells. Moreover, tyrosine 701 and serine 727 phosphorylation of STAT1 were dramatically reduced by LSP pretreatment in IFN-γ-stimulated HepG2 cells. Furthermore phosphorylation of JAK-1 and JAK-2 was also inhibited by LSP. Additionally, two IDO promoters (GAS and ISRE) were inhibited in cells pretreated with LSP prior to IFN-γ exposure. These findings suggest that LSP exerts antitumor effects on HepG2 cells by inhibiting IDO via JAK-PKC-δ-STAT1 signaling pathway.
本研究探讨了来自硫磺菌子实体的多糖(LSP,25 和 100μg/ml)对 HepG2 细胞中免疫抑制酶吲哚胺 2,3-双加氧酶(IDO)的作用及其可能的作用机制。IFN-γ 刺激后,LSP 处理显著抑制了 LSP 处理的 HepG2 细胞中 IDO 的表达和犬尿氨酸的产生。与此一致的是,与 IFN-γ 处理的对照细胞相比,用 LSP 预处理的 HepG2 细胞的培养基提高了原代 CD4+和 CD8+T 细胞的存活率。此外,LSP 预处理可显著降低 IFN-γ 刺激的 HepG2 细胞中 STAT1 的酪氨酸 701 和丝氨酸 727 磷酸化。此外,LSP 还抑制了 JAK-1 和 JAK-2 的磷酸化。此外,在 IFN-γ 暴露前用 LSP 预处理的细胞中抑制了两个 IDO 启动子(GAS 和 ISRE)。这些发现表明,LSP 通过 JAK-PKC-δ-STAT1 信号通路抑制 IDO 发挥对 HepG2 细胞的抗肿瘤作用。